Legal reform can be key to pharma innovation bonanza

Legal reform can be key to pharma innovation bonanza

As countries are in the race to latch onto new investment from the innovative pharma industry, Vietnam is being urged to improve its legal system to increase its competitiveness.
Vietnam's pharma sector shows potential

Vietnam's pharma sector shows potential

With robust human resources and new regulatory reforms, Vietnam's pharmaceutical sector could become an attractive destination for global investment.
MPI calls on investors to make suggestions in pharma sector

MPI calls on investors to make suggestions in pharma sector

The Ministry of Planning and Investment has called on investors and manufacturers to contribute opinions and proposals to attract more investment capital and receive technology transfer to promote the development of the pharmaceutical sector of Vietnam.
Vietnam at the crossroads: The race to secure pharma investment

Vietnam at the crossroads: The race to secure pharma investment

The first panel session from VIR's event, Realising Resolution 29: New Approaches for Pharma-Healthcare Development, on July 20 drew significant attention.
VIR to host health conference on July 20

VIR to host health conference on July 20

Around 200 representatives will gather at a health conference on July 20 to discuss innovative approaches to pharma-healthcare development.
Policy tweaks can tap pharma investment trends

Policy tweaks can tap pharma investment trends

Since 2015, Vietnam’s pharmaceutical sector has accomplished several significant achievements, thus taking its first step in attracting the attention of both prospective domestic and foreign investors as well as major pharma corporations in investing and collaborating with Vietnam.
Fostering pharma-healthcare growth and the spillover effects

Fostering pharma-healthcare growth and the spillover effects

Vietnam’s pharma and healthcare sector is entering a new stage of development, requiring the adoption of innovative approaches and clearly defined policy priorities to achieve long-term goals.
Fresh mindsets called for in post-pandemic healthcare

Fresh mindsets called for in post-pandemic healthcare

As traditional approaches prove outdated, players are seeking innovative methods in Vietnam’s development of the pharma and healthcare sector.
Multinational pharma groups keen on robust partnerships

Multinational pharma groups keen on robust partnerships

After making gains in 2022, multinational corporations will prioritise strengthening local partnerships to support their ambition of transforming the treatment landscape – but they are also pleading for further legal clarity.
Top pharma names advocate for sweeping legal revamps

Top pharma names advocate for sweeping legal revamps

With the Ministry of Health’s latest pledge to improve upon medical legislation, international businesses continue to pin high hopes on marketing authorisation regulations for medical devices and distribution rights in order to drive their plans forward.
The state of play in healthcare M&As

The state of play in healthcare M&As

Merger and acquisition moves are one of the more effective measures for foreign investors entering the Vietnamese medical and pharmaceutical industry, utilising available factories and inexpensive labour. Ngo Thanh Hai, Nguyen Dieu Quynh, and Le Anh Thu from LNT & Partners offers an overview of the factors and barriers involved when it comes to dealmaking in pharma.
Pharma groups step up competition

Pharma groups step up competition

More international pharma and medical device businesses are rushing to venture further in Vietnam, anticipating wide growth potential.
The legal adaption measures expected from pharma groups

The legal adaption measures expected from pharma groups

Multinational corporations in Vietnam are expecting changes in drug rules to make more business and investment progress. Tran Ngoc Anh, representative of the US-ASEAN Business Council, discussed with VIR’s Bich Thuy the current barriers and expectations stemming from legal adjustments.
Harsher penalties sought as pharma violations continue

Harsher penalties sought as pharma violations continue

Pharma violations involving domestic and foreign-invested enterprises are still on the rise, despite stricter rules being introduced by Vietnamese healthcare authorities
Pharma giants gaining big in 2022

Pharma giants gaining big in 2022

International pharma giants have reported strong results for the first half of 2022, with new plans in the pipeline from many of them in this country.
|< < 1 2 3 4 > >|